ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 271 filers reported holding ALKERMES PLC in Q3 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,398 | -0.2% | 228,388 | +11.5% | 0.00% | 0.0% |
| Q2 2023 | $6,413 | -18.9% | 204,877 | -26.9% | 0.00% | 0.0% |
| Q1 2023 | $7,905 | -4.8% | 280,393 | -11.8% | 0.00% | 0.0% |
| Q4 2022 | $8,303 | -99.9% | 317,786 | +11.2% | 0.00% | -42.9% |
| Q3 2022 | $6,378,000 | +337.1% | 285,652 | +483.7% | 0.01% | +600.0% |
| Q2 2022 | $1,459,000 | +2.1% | 48,941 | -9.9% | 0.00% | 0.0% |
| Q1 2022 | $1,429,000 | -87.7% | 54,315 | -89.1% | 0.00% | -50.0% |
| Q4 2021 | $11,596,000 | +411.3% | 498,480 | +577.9% | 0.00% | +100.0% |
| Q3 2021 | $2,268,000 | +278.0% | 73,537 | +200.9% | 0.00% | – |
| Q2 2021 | $600,000 | -70.9% | 24,440 | -77.9% | 0.00% | -100.0% |
| Q1 2021 | $2,064,000 | +341.0% | 110,445 | +369.9% | 0.00% | – |
| Q4 2020 | $468,000 | +0.2% | 23,503 | -16.5% | 0.00% | – |
| Q3 2020 | $467,000 | -70.0% | 28,156 | -64.9% | 0.00% | -100.0% |
| Q2 2020 | $1,556,000 | -21.3% | 80,156 | -41.6% | 0.00% | 0.0% |
| Q1 2020 | $1,978,000 | -61.5% | 137,139 | -45.6% | 0.00% | -50.0% |
| Q4 2019 | $5,138,000 | -4.9% | 251,875 | -9.1% | 0.00% | -33.3% |
| Q3 2019 | $5,402,000 | -50.2% | 276,938 | -42.5% | 0.00% | -57.1% |
| Q2 2019 | $10,852,000 | +224.3% | 481,447 | +425.2% | 0.01% | +250.0% |
| Q1 2019 | $3,346,000 | +62.7% | 91,677 | +31.6% | 0.00% | +100.0% |
| Q4 2018 | $2,056,000 | -44.9% | 69,646 | -20.8% | 0.00% | -50.0% |
| Q3 2018 | $3,731,000 | +146.6% | 87,927 | +139.0% | 0.00% | +100.0% |
| Q2 2018 | $1,513,000 | -60.0% | 36,793 | -43.6% | 0.00% | -66.7% |
| Q1 2018 | $3,783,000 | +33.3% | 65,258 | +25.8% | 0.00% | +50.0% |
| Q4 2017 | $2,838,000 | +19.6% | 51,874 | +11.1% | 0.00% | 0.0% |
| Q3 2017 | $2,373,000 | +18.3% | 46,705 | +35.0% | 0.00% | +100.0% |
| Q2 2017 | $2,006,000 | -55.8% | 34,595 | -55.4% | 0.00% | -80.0% |
| Q1 2017 | $4,538,000 | -6.8% | 77,574 | -11.4% | 0.01% | 0.0% |
| Q4 2016 | $4,867,000 | +82.6% | 87,564 | +54.6% | 0.01% | +66.7% |
| Q3 2016 | $2,665,000 | +121.9% | 56,654 | +103.6% | 0.00% | +200.0% |
| Q2 2016 | $1,201,000 | -57.2% | 27,824 | -66.3% | 0.00% | -80.0% |
| Q1 2016 | $2,804,000 | +81.0% | 82,449 | +320.7% | 0.01% | +150.0% |
| Q4 2015 | $1,549,000 | -59.2% | 19,597 | -70.1% | 0.00% | -50.0% |
| Q3 2015 | $3,797,000 | -70.3% | 65,498 | -67.2% | 0.00% | -71.4% |
| Q2 2015 | $12,771,000 | +509.0% | 199,531 | +470.7% | 0.01% | +600.0% |
| Q1 2015 | $2,097,000 | -62.0% | 34,961 | -63.3% | 0.00% | -66.7% |
| Q4 2014 | $5,521,000 | +104.3% | 95,222 | +48.0% | 0.01% | +100.0% |
| Q3 2014 | $2,703,000 | -38.7% | 64,344 | -27.1% | 0.00% | -25.0% |
| Q2 2014 | $4,410,000 | -62.5% | 88,224 | -67.0% | 0.00% | -69.2% |
| Q1 2014 | $11,758,000 | +1017.7% | 267,217 | +916.0% | 0.01% | – |
| Q4 2013 | $1,052,000 | -78.5% | 26,301 | -84.6% | 0.00% | -100.0% |
| Q2 2013 | $4,883,000 | – | 170,246 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |